TY - CHAP
T1 - Adverse Drug Reactions in Older People
T2 - A Twenty-First Century View
AU - Randles, Mary
AU - O’Mahony, Denis
N1 - Publisher Copyright:
© 2023, Springer Nature Switzerland AG.
PY - 2023
Y1 - 2023
N2 - Adverse drug reactions (ADRs) represent a growing threat to the safety and welfare of older people in all care settings. The risk of an older person experiencing a clinically serious ADR is determined by several key factors, principally exposure to polypharmacy, degree of frailty, concurrent impairment of major organ function and the presence of inappropriate medications. ADRs in older people are considered a public health problem, given the increasing numbers of people in the general population who experience ADRs due the current demographic shifts towards ageing in most countries. ADRs are also highly costly, accounting for approximately 10% of all acute unselected hospitalisations in older people, compared to approximately 6% in the general adult population. ADRs are mostly predictable and, therefore, preventable. Scrutiny of older patients’ medications, particularly at points of care transition, using validated assessment tools for detection of inappropriate medications can help to minimise the prevalence of ADRs. All clinical staff dealing with older patients should be aware that ADRs often present with non-specific symptoms such as confusion, poor appetite, lethargy, altered bowel habit and falls that can be easily but erroneously ascribed to new age-related symptoms; this is a particular risk in the oldest and frailest patients. Clinicians should, therefore, always consider that new symptoms could result from ADRs and should maintain a high degree of suspicion of an iatrogenic basis for new symptoms, particularly if symptoms coincide with the introduction of new medication.
AB - Adverse drug reactions (ADRs) represent a growing threat to the safety and welfare of older people in all care settings. The risk of an older person experiencing a clinically serious ADR is determined by several key factors, principally exposure to polypharmacy, degree of frailty, concurrent impairment of major organ function and the presence of inappropriate medications. ADRs in older people are considered a public health problem, given the increasing numbers of people in the general population who experience ADRs due the current demographic shifts towards ageing in most countries. ADRs are also highly costly, accounting for approximately 10% of all acute unselected hospitalisations in older people, compared to approximately 6% in the general adult population. ADRs are mostly predictable and, therefore, preventable. Scrutiny of older patients’ medications, particularly at points of care transition, using validated assessment tools for detection of inappropriate medications can help to minimise the prevalence of ADRs. All clinical staff dealing with older patients should be aware that ADRs often present with non-specific symptoms such as confusion, poor appetite, lethargy, altered bowel habit and falls that can be easily but erroneously ascribed to new age-related symptoms; this is a particular risk in the oldest and frailest patients. Clinicians should, therefore, always consider that new symptoms could result from ADRs and should maintain a high degree of suspicion of an iatrogenic basis for new symptoms, particularly if symptoms coincide with the introduction of new medication.
KW - Adverse drug event
KW - Adverse drug reaction
KW - Iatrogenic injury
KW - Older people
KW - Patient safety
KW - Polypharmacy
KW - Prevention
UR - https://www.scopus.com/pages/publications/85163687446
U2 - 10.1007/978-3-031-28061-0_6
DO - 10.1007/978-3-031-28061-0_6
M3 - Chapter
AN - SCOPUS:85163687446
T3 - Practical Issues in Geriatrics
SP - 69
EP - 80
BT - Practical Issues in Geriatrics
PB - Springer Nature
ER -